Inforlife Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INFORLIFE, and when can generic versions of INFORLIFE drugs launch?
INFORLIFE has eleven approved drugs.
There are two US patents protecting INFORLIFE drugs.
There is one patent family member on INFORLIFE drugs in one country and fourteen supplementary protection certificates in six countries.
Drugs and US Patents for Inforlife
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inforlife | NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 203978-001 | Apr 17, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Inforlife | ZOLEDRONIC ACID | zoledronic acid | INJECTABLE;INTRAVENOUS | 203231-001 | Aug 2, 2013 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Inforlife | ACETAMINOPHEN | acetaminophen | SOLUTION;INTRAVENOUS | 215403-001 | May 3, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Inforlife | ZOLEDRONIC ACID | zoledronic acid | INJECTABLE;INTRAVENOUS | 202828-001 | Sep 23, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Inforlife | METRONIDAZOLE IN PLASTIC CONTAINER | metronidazole | INJECTABLE;INJECTION | 206191-001 | Feb 25, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Inforlife | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 215700-002 | Sep 15, 2022 | RX | Yes | Yes | 10,888,534 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Inforlife Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2020217079 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Inforlife Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1429780 | 13C0012 | France | ⤷ Sign Up | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
1429780 | SPC/GB12/058 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
1429780 | 122012000070 | Germany | ⤷ Sign Up | PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808 |
0206283 | 98C0041 | Belgium | ⤷ Sign Up | PRODUCT NAME: LEVOFLOXACINUM HEMIHYDRICUM; NAT. REGISTRATION NO/DATE: 354 IS 370 F3 19980624; FIRST REGISTRATION: GB 134020011 19970606 |
0275821 | SPC/GB01/039 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ZOLEDRONIC ACID OPTIONALLY IN THE FORM OF A SALT THEREOF; NATIONAL REGISTRATION NO/DATE: EU/1/01/176/001-003 20010320; FIRST REGISTRATION: CH 55463 20001128 |
0206283 | C980016 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LEVOFLOXACINE, DESGEWENST IN DE VORM VAN EEN SOLVAAT, IN HET BIJZONDER LEVOFLOXACINE-HEMIHYDRAAT; NAT. REGISTRATION NO/DATE: RVG 21810 - RVG 21812 19971209; FIRST REGISTRATION: GB 13402/0011 - 13402/0013 19970606 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.